BIPSX (ProFunds:Biotech;Svc)
Net Asset Value: 122.31
1-Day Return:
1.53 (1.27%)
YTD Return as of 4/4/13: 38.63%
Classification: Diversified Lvg Funds Objective: Equity Leverage Open to New Investors: Yes
Lipper Rating
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
| Growth of $10,000
Total Returns (As of 4/04/2013)
More| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 38.63 | 81.12 | 31.40 | 19.44 | 15.95 |
| Classification | 12.48 | 15.78 | 11.41 | -1.86 | 6.81 |
| Index (S&P 500) | NA | NA | NA | NA | NA |
| % Rank in Class (1-best,100=worst) | 4 | 2 | 3 | 2 | 8 |
Fund Stats
More| Investment Objective: | Equity Leverage |
|---|---|
| Net Assets ($Mil) | 7.30 |
| Inception Date: | 6/19/00 |
| Manager Name, Tenure | Hratch Najarian, 2011 |
| Expense Ratio: | 2.73% |
|
Sales Charge:
Load Type:
|
Level Load 0.00% 0.00% |
Top 10 Holdings (As of 7/31/12)
More| Company Name | Symbol | % Net Assets |
|---|---|---|
| Amgen Inc Ord | AMGN | 12.15 |
| Gilead Sciences Inc Ord | GILD | 7.70 |
| Biogen Idec Inc Ord | BIIB | 6.65 |
| Celgene Corp Ord | CELG | 5.67 |
| Alexion Pharmaceuticals Inc Ord | ALXN | 3.80 |
| Vertex Pharmaceuticals Inc Ord | VRTX | 1.93 |
| Regeneron Pharmaceuticals Inc Ord | REGN | 1.85 |
| Life Technologies Corp Ord | LIFE | 1.48 |
| Illumina Inc Ord | ILMN | 0.96 |
| Onyx Pharmaceuticals Inc Ord | ONXX | 0.88 |
| % of Total Holdings | 43.07 | |
